These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1120981)

  • 21. Evidence for sulfhydryl groups at the active site of catechol-O-methyltransferase.
    Borchardt RT; Thakker DR
    Biochim Biophys Acta; 1976 Oct; 445(3):598-609. PubMed ID: 9991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.
    Zhao Z; Harrison ST; Schubert JW; Sanders JM; Polsky-Fisher S; Zhang NR; McLoughlin D; Gibson CR; Robinson RG; Sachs NA; Kandebo M; Yao L; Smith SM; Hutson PH; Wolkenberg SE; Barrow JC
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2952-2956. PubMed ID: 27133481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of ring-fluorination on the rate of O-methylation of dihydroxyphenylalanine (DOPA) by catechol-O-methyltransferase: significance in the development of 18F-PETT scanning agents.
    Creveling CR; Kirk KL
    Biochem Biophys Res Commun; 1985 Aug; 130(3):1123-31. PubMed ID: 3927916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor.
    Palma PN; Bonifácio MJ; Loureiro AI; Wright LC; Learmonth DA; Soares-da-Silva P
    Drug Metab Dispos; 2003 Mar; 31(3):250-8. PubMed ID: 12584150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.
    Lotta T; Vidgren J; Tilgmann C; Ulmanen I; Melén K; Julkunen I; Taskinen J
    Biochemistry; 1995 Apr; 34(13):4202-10. PubMed ID: 7703232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    Biochem Pharmacol; 1993 May; 45(10):1973-81. PubMed ID: 8512582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. beta-phenylethylamine effect on brain and blood catechol-O-methyltransferase activity.
    Hannan CJ
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1141-6. PubMed ID: 3714772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of ortho- and meta-nitrated inhibitors of catechol-O-methyltransferase: interactions with the active site and regioselectivity of O-methylation.
    Palma PN; Rodrigues ML; Archer M; Bonifácio MJ; Loureiro AI; Learmonth DA; Carrondo MA; Soares-da-Silva P
    Mol Pharmacol; 2006 Jul; 70(1):143-53. PubMed ID: 16618795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of 6,7-dimethoxy 4-(4'-chlorobenzyl)isoquinoline. II. Role of liver catechol O-methyltransferase and glutathione.
    Servin AL; Wicek D; Oryszczyn MP; Jacquot C; Lussiana JP; Christinaki H; Viel C
    Xenobiotica; 1987 Dec; 17(12):1381-91. PubMed ID: 3439189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
    Meyer MR; Maurer HH
    Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of catechol O-methyltransferase.
    Vidgren J; Svensson LA; Liljas A
    Nature; 1994 Mar; 368(6469):354-8. PubMed ID: 8127373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the tight-binding nature of tolcapone inhibition of soluble and membrane-bound rat brain catechol-O-methyltransferase.
    Borges N; Vieira-Coelho MA; Parada A; Soares-da-Silva P
    J Pharmacol Exp Ther; 1997 Aug; 282(2):812-7. PubMed ID: 9262345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoaffinity purification and partial amino acid sequence analysis of catechol-O-methyltransferase from pig liver.
    Bertocci B; Garotta G; Da Prada M; Lahm HW; Zürcher G; Virgallita G; Miggiano V
    Biochim Biophys Acta; 1991 Oct; 1080(2):103-9. PubMed ID: 1932084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacodynamic evaluation of novel Catechol-O-methyltransferase inhibitors.
    Pinheiro SD; Serrão MP; Silva T; Borges F; Soares-da-Silva P
    Eur J Pharmacol; 2019 Mar; 847():53-60. PubMed ID: 30685433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate.
    Lu H; Meng X; Yang CS
    Drug Metab Dispos; 2003 May; 31(5):572-9. PubMed ID: 12695345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human catechol-O-methyltransferase-mediated dopamine O-methylation by daphnetin and its Phase II metabolites.
    Liang SC; Ge GB; Xia YL; Pei-Pei D; Ping W; Qi XY; Cai-Xia T; Ling Y
    Xenobiotica; 2017 Jun; 47(6):498-504. PubMed ID: 27435571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methyl conjugation in uraemia: catechol-O-methyltransferase.
    Pazmiño PA; Weinshilboum RM
    Br J Clin Pharmacol; 1980 Nov; 10(5):509-18. PubMed ID: 7437264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics and crystal structure of catechol-o-methyltransferase complex with co-substrate and a novel inhibitor with potential therapeutic application.
    Bonifácio MJ; Archer M; Rodrigues ML; Matias PM; Learmonth DA; Carrondo MA; Soares-Da-Silva P
    Mol Pharmacol; 2002 Oct; 62(4):795-805. PubMed ID: 12237326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.